February 24, 2020Eisai Withdraws Belviq Over Cancer ConcernsThe agency announced a possible risk of cancer associated with the drug based on clinical trial data.
February 20, 2020FDA Publishes Details on Gene-Drug InteractionsThe FDA has released a new table listing certain gene-drug interactions backed by scientific evidence that appear on agency-approved drug labeling.
February 6, 2020FDA Calls for Voluntary Withdrawal of Injectable Bacitracin The withdrawal does not impact approved topical or ophthalmic products.
